X-44148804-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025184.4(EFHC2):āc.2241G>Cā(p.Glu747Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000538 in 111,566 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025184.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFHC2 | NM_025184.4 | c.2241G>C | p.Glu747Asp | missense_variant | 15/15 | ENST00000420999.2 | NP_079460.2 | |
EFHC2 | XM_047442535.1 | c.2148G>C | p.Glu716Asp | missense_variant | 14/14 | XP_047298491.1 | ||
EFHC2 | XM_006724562.3 | c.1653G>C | p.Glu551Asp | missense_variant | 14/14 | XP_006724625.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFHC2 | ENST00000420999.2 | c.2241G>C | p.Glu747Asp | missense_variant | 15/15 | 1 | NM_025184.4 | ENSP00000404232.2 | ||
EFHC2 | ENST00000343571.3 | n.562G>C | non_coding_transcript_exon_variant | 5/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000538 AC: 6AN: 111566Hom.: 0 Cov.: 23 AF XY: 0.0000889 AC XY: 3AN XY: 33762
GnomAD4 exome Cov.: 28
GnomAD4 genome AF: 0.0000538 AC: 6AN: 111566Hom.: 0 Cov.: 23 AF XY: 0.0000889 AC XY: 3AN XY: 33762
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.2241G>C (p.E747D) alteration is located in exon 15 (coding exon 15) of the EFHC2 gene. This alteration results from a G to C substitution at nucleotide position 2241, causing the glutamic acid (E) at amino acid position 747 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at